Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults

被引:46
作者
Harp, JB [1 ]
Henry, SA [1 ]
DiGirolamo, M [1 ]
机构
[1] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA
来源
OBESITY RESEARCH | 2002年 / 10卷 / 10期
关键词
angiotensin; plasma renin activity; aldosterone; blood pressure;
D O I
10.1038/oby.2002.134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To study the effect of dietary weight loss, postural change, and an oral glucose load on serum angiotensin-converting enzyme (ACE) activity in obese adults. Research Methods and Procedures: Sixteen obese adult men and women with a mean body mass index of 35.7 +/- 4.3 kg/m(2) were studied after 1 week on a maintenance energy lead-in diet and after 5 weeks on an identical but 40% reduced-energy diet provided by the General Clinical Research Center (GCRC). ACE activity was measured spectrophotometrically. Plasma renin activity and serum aldosterone were measured by radioirnmunoassay. Results: All subjects lost weight, with a mean decrease in body weight of 7.0 +/- 2.1 kg or 6 +/- 3% of initial body weight (p < 0.00001). Systolic and diastolic blood pressure. supine plasma renin activity, and serum aldosterone levels decreased with weight loss (p < 0.05). Supine ACE activity decreased 23 +/- 12% with weight loss (p < 0.00001). Standing ACE activity, which was significantly higher than supine ACE activity before and after weight loss (p < 0.05). also decreased 18 +/- 17% with weight loss (p = 0.0007). A 75-g oral glucose load had no effect on serum ACE activity over a 3-hour period. Discussion: In obese adults, serum ACE activity declines with modest weight loss, increases with postural change, and is unaffected by an oral glucose load.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 39 条
  • [1] ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33
  • [2] ASHWELL M, 1982, INT J OBESITY, V6, P143
  • [3] DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION
    CAMBIEN, F
    POIRIER, O
    LECERF, L
    EVANS, A
    CAMBOU, JP
    ARVEILER, D
    LUC, G
    BARD, JM
    BARA, L
    RICARD, S
    TIRET, L
    AMOUYEL, P
    ALHENCGELAS, F
    SOUBRIER, F
    [J]. NATURE, 1992, 359 (6396) : 641 - 644
  • [4] ACE, angiotensinogen and obesity: A potential pathway leading to hypertension
    Cooper, R
    McFarlaneAnderson, N
    Bennett, FI
    Wilks, R
    Puras, A
    Tewksbury, D
    Ward, R
    Forrester, T
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (02) : 107 - 111
  • [5] DORNFELD LP, 1987, KIDNEY INT, V32, pS254
  • [6] DYER AR, 1989, J HUM HYPERTENS, V3, P299
  • [7] ERDOS EG, 1987, LAB INVEST, V56, P345
  • [8] PLASMA ENDOTHELIN-1 LEVELS IN OBESE HYPERTENSIVE AND NORMOTENSIVE MEN
    FERRI, C
    BELLINI, C
    DESIDERI, G
    DIFRANCESCO, L
    BALDONCINI, R
    SANTUCCI, A
    DEMATTIA, G
    [J]. DIABETES, 1995, 44 (04) : 431 - 436
  • [9] TISSUE-SPECIFIC NUTRITIONAL REGULATION OF ANGIOTENSINOGEN IN ADIPOSE-TISSUE
    FREDERICH, RC
    KAHN, BB
    PEACH, MJ
    FLIER, JS
    [J]. HYPERTENSION, 1992, 19 (04) : 339 - 344
  • [10] Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride - A meta-analysis
    Graudal, NA
    Galloe, AM
    Garred, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (17): : 1383 - 1391